If you need more lookups,
subscriptions start at $34 USD/month.
Bobby Adamov Location
Madison, WI, US
Bobby Adamov Work
Vice President, Business Operations and Vice President, Rare Disease and Vice President, Sales @ (January 2018 - Present)
Vice President, Sales and Training @ (January 2016 - January 2018)
Sr. National Sales Director, Hospital and Rare Disease @ (January 2011 - January 2015)
Area Sales Director, East @ (January 2009 - January 2011)
Product Manager, Marketing @ (January 2007 - January 2009)
Regional Sales Manager @ (January 2003 - January 2007)
District Sales Manager @ Adams Laboratories, Inc. (January 2002 - January 2003)
Sales Representative @ Adams Laboratories, Inc. (January 1999 - January 2002)
Bobby Adamov Education
UNC Kenan-Flagler Business School
Master of Business Administration (MBA) (Concentration: Corporate Finance and Strategy)
University of Wisconsin-Madison
Bachelor of Arts (BA) (Behavioral Sciences & Law, Sociology)
Bobby Adamov Skills
Start-ups
Sales Force Development
Pharmaceutical Sales
Hospital Sales
Rare Diseases
Orphan Drugs
Leadership
Product Launch
Sales
Business Strategy
Pharmaceutical Industry
Marketing
People Development
Sales Operations
Medical Devices
Managed Care
Gastroenterology
Sales Effectiveness
Biotechnology
Sales Management
Oncology
Start Ups
Teaching
Healthcare
Management
Bobby Adamov Summary
Bobby Adamov, based in Madison, WI, US, is currently a Vice President, Business Operations and Vice President, Rare Disease and Vice President, Sales at Exact Sciences. Bobby Adamov brings experience from previous roles at Melinta Therapeutics and Salix Pharmaceuticals. Bobby Adamov holds a Master of Business Administration (MBA) in Concentration: Corporate Finance and Strategy @ UNC Kenan-Flagler Business School. With a robust skill set that includes Start-ups, Sales Force Development, Pharmaceutical Sales, Hospital Sales, Rare Diseases and more. Bobby Adamov has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Bobby Adamov?
Find contact details for 700 million professionals.